title: The treating scenario in genitourinary oncology: what is new? Part 2.
abstract: The objectives of this innovative meeting were to discuss developments in the management of genitourinary cancer worldwide and how Italian clinicians could harness these innovations in their everyday practice. The 2-day meeting was divided into two sessions covering kidney and prostate cancer, and a large part was given over to the presentation and discussion of new recently presented data at major international congresses in 2012. There were no restrictions on content and all subjects from pathology, surgery and genetics to therapy and patient outcomes were covered.
authors.affiliation: UOC Medical Oncology, Department of Oncology, AUSL8 Arezzo, Italy. sergio.bracarda@usl8.toscana.it
authors.forename: Sergio
authors.initials: S
authors.lastname: Bracarda
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Montironi
authors.forename: Camillo
authors.initials: C
authors.lastname: Porta
authors.forename: Cezary
authors.initials: C
authors.lastname: Szczylic
authors.forename: Alessandra
authors.initials: A
authors.lastname: Bearz
authors.forename: Giacomo
authors.initials: G
authors.lastname: Cartenì
authors.forename: Joaquim
authors.initials: J
authors.lastname: Bellmunt
mesh_terms: D005260:Female; D006801:Humans; D007558:Italy; D007680:Kidney Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy; D014565:Urogenital Neoplasms / Q000235:genetics* / Q000473:pathology* / Q000601:surgery* / Q000628:therapy